These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 25047810)
1. Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model. Kim Y; Lee HG; Dmitrieva N; Kim J; Kaur B; Friedman A PLoS One; 2014; 9(7):e102499. PubMed ID: 25047810 [TBL] [Abstract][Full Text] [Related]
2. Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Dmitrieva N; Yu L; Viapiano M; Cripe TP; Chiocca EA; Glorioso JC; Kaur B Clin Cancer Res; 2011 Mar; 17(6):1362-72. PubMed ID: 21177410 [TBL] [Abstract][Full Text] [Related]
4. The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus. Fujii K; Kurozumi K; Ichikawa T; Onishi M; Shimazu Y; Ishida J; Chiocca EA; Kaur B; Date I Cancer Gene Ther; 2013 Aug; 20(8):437-44. PubMed ID: 23827879 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic Virotherapy in Glioma Tumors. Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507 [TBL] [Abstract][Full Text] [Related]
8. Oncolytic Virotherapy for the Treatment of Malignant Glioma. Foreman PM; Friedman GK; Cassady KA; Markert JM Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902 [TBL] [Abstract][Full Text] [Related]
10. Effects of CCN1 and Macrophage Content on Glioma Virotherapy: A Mathematical Model. Jacobsen K; Russell L; Kaur B; Friedman A Bull Math Biol; 2015 Jun; 77(6):984-1012. PubMed ID: 25758754 [TBL] [Abstract][Full Text] [Related]
11. Oncolytic Viruses for Malignant Glioma: On the Verge of Success? Suryawanshi YR; Schulze AJ Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501 [TBL] [Abstract][Full Text] [Related]
13. [Oncolytic virus therapy for malignant brain tumors]. Ino Y; Todo T Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01. Vera B; Martínez-Vélez N; Xipell E; Acanda de la Rocha A; Patiño-García A; Saez-Castresana J; Gonzalez-Huarriz M; Cascallo M; Alemany R; Alonso MM PLoS One; 2016; 11(1):e0147211. PubMed ID: 26808201 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas. Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357 [TBL] [Abstract][Full Text] [Related]
16. Viruses, gene therapy and stem cells for the treatment of human glioma. Kyritsis AP; Sioka C; Rao JS Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531 [TBL] [Abstract][Full Text] [Related]